LSE:SN. (Smith & Nephew Plc)
About SN.
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Smith & Nephew Plc (LSE: SN.) Latest News
Investing Articles
What Labour’s win means for UK stocks and the FTSE
Investing Articles
Be prepared for a FTSE 100 correction, says the Bank of England
Value Shares
Down 50%, this FTSE dividend stock looks like a steal to me
Investing For Beginners
2 UK stocks that could do well out of the general election
Investing Articles
Is this unloved FTSE 100 hero about to make investors rich all over again?
Investing Articles
4 UK shares Fools think could be takeover targets
Value Shares
2 dirt cheap UK stocks to consider buying as the FTSE 100 hits new all-time highs
Investing Articles
I love the look of this FTSE 100 giant
Investing Articles
Down 27%, but set for major growth, this hidden FTSE gem looks cheap to me
Investing Articles
Is this the most undervalued FTSE stock?
Investing Articles
How I’m aiming for a winning Stocks & Shares ISA in 2024